Acquisitions Purchase
Recent Private Equity-Backed Biotechnology Acquisitions
Review the export, choose years, and enter your email to continue.
Full Export
Purchase the full list for Private Equity-Backed Biotechnology Acquisitions
164 rows · from $164 · CSV + XLSX
Show details
Hide details
Full Export
Purchase the full list for Private Equity-Backed Biotechnology Acquisitions
164 rows · from $164 · CSV + XLSX
Get a point-in-time export of all tracked rows for this page. We email the file immediately after purchase.
What the export looks like
| Date | Title | Buyers | Targets | Industry | Transaction Type | Location | Closing Status |
|---|---|---|---|---|---|---|---|
| 2026-10-30 | Hologic to Acquire Reveal Genomics | Hologic | Reveal Genomics | Biotechnology | Buyout | Catalonia, Spain | Presumed closed |
| 2026-10-24 | Investor Group Provides $120 Million Private Placement to Bolt Biotherapeutics | Deep Track Capital; ADAR1 Capital; Andreessen Horowitz; LYFE Capital; Coastlands Capital; Eventide Asset Management; Casdin Capital; Curie.Bio; SilverArc Capital; Soleus Capital; Deviation Capital; YK Bioventures | Bolt Biotherapeutics | Biotechnology | Growth capital | California, United States | Presumed closed |
| 2026-09-23 | Enveda Raises $311 Million in Series E Financing Led by Catalio Capital Management | Catalio Capital Management; Durable Capital Partners; ICONIQ; Lightspeed; Surveyor Capital; T. Rowe Price Investment Management; Digitalis Ventures; Sovereign Wealth Fund (unnamed); Alderline Group; Baillie Gifford; Premji Invest; FPV Ventures; True Ventures; Kinnevik; Dimension; Lifeforce Capital; Lux Capital | Enveda | Biotechnology | Growth capital | Colorado, United States | Confirmed closed |
Each purchase includes both CSV and XLSX files, emailed to you immediately.